Lung Kee Group logo

Lung Kee Group(SEHK) 0255

Market CapHK$865.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)+1,899%
5 Year-62%
1 Year-26%
1 Month-2%
HK$1.37
+0.00%
+0.00Today
Lung Kee Group last closing stock price
MetricPriceDate
Last closeHKD 1.372026-10-12
Lung Kee Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%HKD 1.372026-10-05
1 month-2.14%HKD 1.402026-09-11
3 month-7.43%HKD 1.482026-07-14
Year to date-19.88%HKD 1.712025-12-31
1 year-26.34%HKD 1.862025-10-10
3 year-10.46%HKD 1.532023-10-13
5 year-61.62%HKD 3.572021-10-12
Since inception+1,899.12%HKD 0.071993-03-25

Lung Kee Group Financials at a Glance

Market Cap

HK$865.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$2.66B

Net Income (TTM)

-HK$22.74M

EPS (TTM)

-HK$0.05

P/E Ratio

-29.35

Dividend

HK$0.20

Beta (Volatility)

-0.01 (Low)

Price

HK$1.37

Volume

2,000

Open

HK$1.37

Previous Close

HK$1.37

Daily Range

HK$1.37 - HK$1.37

52-Week Range

HK$1.33 - HK$1.98

Estimated Earnings Date

Mar 21, 2025

0255 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lung Kee Group

Lung Kee Group Holdings Limited is an investment holding company specializing in the manufacturing and marketing of mould bases and related products. The company operates in the People's Republic of China and internationally, while also engaging in property investment and corporate management activities.

Products and Services
  • Manufactures mould bases for various industrial applications
  • Offers related products and services in the machinery sector
  • Engages in property investment and corporate management
Growth Outlook
  • Revenue increased to HKD 568 million in Q2 2026
  • Strong cash flow with net cash provided by operating activities of HKD 136 million
  • Significant market potential in the industrial machinery sector
Financial Highlights
  • Trailing twelve months (TTM) revenue of HKD 2.5 billion
  • Current ratio of 6.38 indicates strong liquidity
  • Dividend yield of 14.65% reflects attractive returns for investors
Lung Kee Group Holdings Limited has shown resilience in its financial performance, with a notable revenue increase in the latest quarter. The company's strong liquidity position, as indicated by a current ratio of 6.38, suggests it is well-equipped to meet short-term obligations. Additionally, the impressive dividend yield of 14.65% may attract income-focused investors. The industrial machinery sector presents significant growth opportunities, positioning Lung Kee Group for potential expansion and increased market share.
AI Generated • Oct 15, 2026

Industry

Machinery

Sector

Industrials

Employees

2,800

CEO

Yuk Lung Siu

Website

www.irasia.com/listco/hk/lkm

Headquarters

Hong Kong, HK

0255 Financials

Key Financial Metrics (TTM)

Gross Margin

17.54%

Operating Margin

-5.85%

Net Income Margin

-2.45%

Return on Equity

-1.92%

Return on Capital

-3.20%

Return on Assets

-1.68%

Earnings Yield

-3.41%

Dividend Yield

14.65%

Payout Ratio

-4.30%

Stock Overview

Market Cap

HK$865.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

634.01M

Volume

2.00K

Avg. Volume

23.70K

Financials (TTM)

Gross Profit

HK$1.09B

Operating Income

HK$389.27M

EBITDA

HK$245.71M

Operating Cash Flow

HK$480.15M

Capital Expenditure

-HK$79.66M

Free Cash Flow

HK$400.49M

Cash & ST Invst.

HK$649.71M

Total Debt

HK$2.79M

Lung Kee Group Performance Analysis

Lung Kee Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 1,601,433,000-29.6%
20232023-12-31HKD 1,449,340,000-9.5%
20242024-12-31HKD 1,553,244,0007.2%
20252025-12-31HKD 1,319,901,000-15.0%
Lung Kee Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-2.0%
Q22025-06-30-10.5%
Q42025-12-31-8.3%
Q22026-06-30-10.0%
Lung Kee Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.03-93.1%
20232023-12-31HKD -0.11N/A
20242024-12-31HKD -0.02-81.2%
20252025-12-31HKD -0.0465.7%
Lung Kee Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31142.7%
Q22025-06-30-134.6%
Q42025-12-31-437.5%
Q22026-06-3045.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$568.34M

-27.6%

Gross Profit

HK$95.43M

-78.4%

Gross Margin

16.79%

N/A

Market Cap

HK$865.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$309.08K

N/A

Employees

2,800

N/A

Net Income

-HK$10.36M

+56.7%

EBITDA

HK$48.50M

-17.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$649.71M

+36.0%

Total Debt

HK$2.79M

-37.6%

Accounts Receivable

HK$132.75M

+17.9%

Inventory

HK$302.10M

-37.1%

Long Term Debt

HK$501.00K

-80.0%

Short Term Debt

HK$2.29M

+16.2%

Return on Assets

-1.68%

N/A

Return on Invested Capital

-4.42%

N/A

Free Cash Flow

HK$119.46M

+49.3%

Operating Cash Flow

HK$136.68M

+46.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About 0255

What is the current price of Lung Kee Group?

Lung Kee Group is trading at HK$1.37 per share.

What is the 52-week range for Lung Kee Group?

Over the past 52 weeks, Lung Kee Group has traded between HK$1.33 and HK$1.98.

How much debt does Lung Kee Group have?

As of the most recent reporting period, Lung Kee Group reported total debt of HK$4.36M.

How much cash does Lung Kee Group have on hand?

Lung Kee Group reported HK$588.63M in cash and cash equivalents in its most recent financial results.

What is Lung Kee Group’s dividend yield?

Lung Kee Group currently has a dividend yield of 14.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services